Clayton, Dubilier & Rice and TPG Capital have clinched a take-private deal for Covetrus that values the animal health tech and services company at approximately $4 billion.
Why it matters: The deal reflects the opportunity to unlock differential value in the private markets relative to living with the constraints of the public markets — and focus on the long-term strategy — in today's uncertain landscape.
